Advanced Cell Technology initiates treatment of higher-dosage cohort in trials Advanced Cell Technology announced treatment of patients in the third patient cohort, in each of its two U.S. clinical trials for forms of macular degeneration.
http://www.theflyonthewall.com/permalinks/entry.php/ACTCid1808259/ACTC-Advanced-Cell-Technology-initiates-treatment-of-higherdosage-cohort-in-trials
http://www.theflyonthewall.com/permalinks/entry.php/ACTCid1808259/ACTC-Advanced-Cell-Technology-initiates-treatment-of-higherdosage-cohort-in-trials
No comments:
Post a Comment